Rating : 9,7/10 (⭐⭐⭐⭐⭐)
🔹Professor Albert Ludolph has been the Medical Director of the University Hospital for Neurology at the University of Ulm since 1996.
🔹He is internationally recognized as an expert in motor system degenerations, such as the fatal nerve disease Amyotrophic Lateral Sclerosis (ALS).
🔹Professor Ludolph's research interests span from the genetic foundations of Amyotrophic Lateral Sclerosis to the optimal clinical care of ALS patients, as well as the development of new medications and therapies.
🔹Due to the degeneration of motor neurons, ALS patients lose control over their movements, speech, and eventually their breathing, leading to their demise. For a long time, there were no effective treatments, but now, medications are slowing down the progression of the disease.
🔹Additionally, insights into nutrition and ventilation are improving the quality of life for these patients.
🔹1979 - 1984: Resident, Board Neurology and Psychiatry (Department of Neurology and Psychiatry, University of Münster FRG)(Prof. G. Brune, Prof. R. Tölle)
🔹1984 - 1985: Stipend, Deutsche Forschungsgemeinschaft: Institute of Neurotoxicology, Albert Einstein College of Medicine, Bronx, New York (Prof. P.S. Spencer, Prof. H.H. Schaumburg)
🔹1985 - 1989: Staff, Department of Neurology, University of Münster (Prof. G. Brune)
🔹1987: Habilitation, Faculty of Medicine, University of Münster, C2 Professor of Neurology
🔹1990 - 1992: Staff Scientist, Visiting Assoc. Prof., Center for Research on Occuputational and Environmental Toxicology, Portland (Oregon)
🔹1992: Staff, Department of Epileptology, University of Bonn (Prof. C.E. Elger)
🔹1993 - 1996: C3 Professor of Neurology, Vice Chairman, Department of Neurology, Humboldt University Berlin (Prof. K.-M. Einhäupl)
🔹1996: C4 Professor of Neurology, Chair, Department of Neurology, University of Ulm
🔹2003: Chair (elected) Academic Neuroscience Center, University of Ulm
🔹2005 - 2009: Deputy Chair and Chair (elected), European ALS-MND-Group
🔹2007: Chair (elected) ALS panel of the EFNS and EAN (since 2014, together with Prof. Vincenzo Silani)
🔹2008: Scientific Advisory Board Thierry Latran Foundation
🔹2008: Chair, Scientific Council of Deutsche Stiftung Querschnittlähmung (DSQ)
🔹2008: Chair, Scientific Council Deutsche Gesellschaft für Muskelkranke
🔹2009: Scientific Advisory Board Member of the Stifterverband der Schilling-Research-Groups for Translational Neuroscience
🔹2009: Chair (elected), World Federation of Neurology, ALS Research Group
🔹2009: Reviewer for Neuroscience Board of the German Research Foundation (DFG)
🔹2010 - 2014: Vice Dean of the Medical Faculty of Ulm
🔹2013: Chair (elected), World Federation of Neurology, ALS Research Group
🔹2014: Delegate of the German Society of Neurology at the World Federation of Neurology
🔹2015 – 2017: Speaker (elected), Clinical Neurosciences Neurowissenschaftliche Gesellschaft (German Society of Neuroscience)
🔹2017 – 2021: Deputy Chair and Chair elected Neurowissenschaftliche Gesellschaft (German Society of Neuroscience)
🔹2017: Chair Scientific Advisory Board Thierry Latran Foundation
🔹Since 2018: Speaker, Site Ulm of the DZNE (Deutsches Zentrum für Neurodegenerative Erkrankungen)
🔹Motor system diseases such as ALS
🔹Stroke (cerebral infarction, cerebral hemorrhage)
🔹Extrapyramidal motor diseases such as Parkinson's disease, atypical Parkinson syndromes, Huntington's disease
🔹Dementia-related diseases such as Alzheimer's disease
🔹Inflammatory diseases of the nervous system such as Multiple Sclerosis, Guillain-Barrè syndrome, Meningitis, and Encephalitis
🔹Epilepsy
🔹Neuromuscular diseases
🔹Neurofibromatosis and other tumor-related diseases of the nervous system
🔹Neurological pain syndromes
